Initially there was no specific way to reverse the anticoagulant well uh uh you know um so okay so I mean effect of dabigatran in the event of well I mean okay I mean uh well you know so you know a major bleeding event, unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.